TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 1 | 3 | 24 | 20 | 37 | -22 | 10 |
| P | %wins | 50 | 100 | 100 | 50 | 50 | 0 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/7/23 17:13 | 8/3/23 | CERE | Cerevel Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Renaud Ronald C Jr | MA | DO | P,CEO | P | 2,009 | 23.96 | 0 | 84 | New | 84 | I | ||||||||||||||
12/2/14 18:42 | 12/2/14 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Renaud Ronald C Jr | MA | D | P | 60 | 11.92 | 3 | 5 | New | 5 | D | -56 | -49 | -43 | 28 | -24 | -12 | -6 | 1 | 2 | -11 | -30 | -10 | |||
3/11/08 10:42 | 3/11/08 | IDIX | Idenix Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Renaud Ronald C Jr | MA | O | CFO | P | 0 | 0.00 | 1 | 15 | New | 15 | D | -80 | -50 | 54 | 76 | -19 | -19 | -23 | -20 | 7 | 4 | 46 | 51 | 103 | -33 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |